Bioengineering: Heart, Lung, Blood & Sleep Disorders

Deadline
Multiple
OPPORTUNITY NO.
RFA-HL-17-015
MECHANISM
R21
RESEARCH AREA(S)
SYNOPSIS

Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases

The purpose of this funding opportunity announcement (FOA) is to seek innovative, high-risk bioengineering research for which preliminary results have not yet been obtained, explore new approaches or concepts that are important to a substantive heart, lung, blood or sleep disorder or disease, support the translation of research into practice, technologies, or commercial products, and to develop trans-disciplinary projects upon which significant future research may be built.  This  program will allow investigators to enter new fields and apply cutting-edge approaches to improve the Nation’s health through bioengineering research.  In particular, ground-breaking studies aimed towards the development of novel agents, materials or coatings related to medical devices and engineered tissues would be uniquely fostered by this FOA.

Deadlines:

  • Pre-Application Submission: 30 days before application submission due date
  • Application Submission: 5:00 PM local time of applicant organization, Jan. 10, 2017; May 10, 2017; Oct. 13, 2017; Jan. 10, 2018; May 10, 2018; Oct. 13, 2018; Jan. 10, 2019; May 10, 2019

ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.